Business Context and Reporting Period
Company: Healthpeak Properties, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 14, 2025
Event: Completion of an underwritten offering of senior notes by Healthpeak OP, LLC, a subsidiary of the Company.
Key Financial Metrics
| Metric | Value |
|---|---|
| Aggregate Principal Amount Offered | $500.0 million |
| Interest Rate | 4.750% |
| Maturity Date | January 15, 2033 |
| Estimated Net Proceeds | Approximately $491.4 million |
| Interest Payment Frequency | Semi-annually in arrears (January 15 and July 15) |
| First Interest Payment Date | January 15, 2026 |
Note: This filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Use of Proceeds
The Company completed a new debt issuance. The estimated net proceeds of approximately $491.4 million are intended for the following purposes:
- Repayment of borrowings outstanding under the Company's commercial paper program.
- General corporate purposes, including:
- Repaying or repurchasing other indebtedness.
- Working capital.
- Acquisitions, development, and redevelopment activities.
- Capital expenditures.
Pending application, proceeds may be invested in short-term securities.
Guidance, Outlook, and Risk Factors
Debt Structure and Seniority:
- The Notes are senior unsecured obligations of Healthpeak OP, LLC.
- They are fully and unconditionally guaranteed on a joint and several basis by Healthpeak Properties, Inc., DOC DR Holdco, LLC, and DOC DR, LLC.
- The Notes are equal in right of payment with existing senior indebtedness but are effectively junior to secured indebtedness and structurally subordinated to liabilities of non-guarantor subsidiaries.
Redemption Terms:
- Pre-Par Call Date (Before November 15, 2032): The Company may redeem the Notes at a price equal to the greater of (i) the present value of remaining payments discounted at the Treasury Rate plus 15 basis points, or (ii) 100% of the principal amount, plus accrued interest.
- On or After Par Call Date: The Company may redeem the Notes at 100% of the principal amount plus accrued interest.
Management Commentary: The filing contains no forward-looking guidance regarding future earnings or operational outlook beyond the specific terms of the debt offering.
Investor Verification Checklist
- Verify the exact amount of commercial paper outstanding to be repaid with the net proceeds.
- Review the Base Indenture (filed February 14, 2025) and Second Supplemental Indenture (filed August 14, 2025) for specific covenants and default provisions.
- Confirm the current status of the Company's secured indebtedness to understand the effective subordination of these new notes.
- Monitor the Company's liquidity position post-issuance to ensure sufficient cash flow for the semi-annual interest payments beginning January 15, 2026.